Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Gosset (LILLE, France). The TLR5 agonist flagellin prevents bacteria-induced chronic obstructive pulmonary disease exacerbations in mice.. 1490

Member's Comments

No comment yet.

Related content which might interest you: IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 TNF and LTA genes and susceptibility to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 488-496 Year: 2002 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005 Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 213s Year: 2007 Altered expression of TLR4 and of beta 2 defensin in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Stable chronic obstructive pulmonary disease-bronchial colonization and inflammatory response Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001